References
- Hendershot CS, Stoner SA, Pantalone DW, et al. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52:180.
- Kalichman SC, Grebler T, Amaral CM, et al. Viral suppression and antiretroviral medication adherence among alcohol using HIV positive adults. Int J Behav Med. 2014;21:811–820.
- Ande A, Sinha N, Rao PSS, et al. Enhanced oxidative stress by alcohol use in HIV + patients: possible involvement of cytochrome P450 2E1 and antioxidant enzymes. AIDS Res Ther. 2015;12:29.
- Molina PE, Simon L, Amedee AM, et al. Impact of alcohol on HIV disease pathogenesis, comorbidities and aging: integrating preclinical and clinical findings. Alcohol Alcohol. 2018;53:439–447.
- Probst C, Parry CDH, Rehm J. HIV/AIDS mortality attributable to alcohol use in South Africa: a comparative risk assessment by socioeconomic status. BMJ Open. 2018;8:e017955.
- Haorah J, Knipe B, Leibhart J, et al. Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction. J Leukoc Biol. 2005;78:1223–1232.
- Braithwaite RS, Bryant KJ. Influence of alcohol consumption on adherence to and toxicity of antiretroviral therapy and survival. Alcohol Res Health. 2010;33:280–287.
- Kumar S, Jin M, Ande A, et al. Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes. Expert Opin Drug Metab Toxicol. 2012;8:1363–1375.
- Durvasula R, Miller TR. Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis. Behav Med. 2014;40:43–52.
- Kumar S, Rao PSS, Earla R, et al. Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems. Expert Opin Drug Metab Toxicol. 2015;11:343–355.
- Jin M, Ande A, Kumar A, et al. Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway. Cell Death Dis. 2013;4:e554.
- Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol. 2014;20:17756–17772.
- Bbosa GS, Kyegombe DB, Anokbonggo WW, et al. Chronic ethanol use in alcoholic beverages by HIV-infected patients affects the therapeutic window of stavudine, lamivudine and nevirapine during the 9-month follow-up period: using chronic alcohol-use biomarkers. J Basic Clin Physiol Pharmacol. 2014;25:1–12.
- Kis O, Robillard K, Chan GNY, et al. The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters. Trends Pharmacol Sci. 2010;31:22–35.
- Fayet Mello A, Buclin T, Franc C, et al. Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration. J Antimicrob Chemother. 2011;66:1573–1581.
- Jin M, Arya P, Patel K, et al. Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages. Alcohol Clin Exp Res. 2011;35:132–139.
- Kumar S, Kumar A. Differential effects of ethanol on spectral binding and inhibition of cytochrome P450 3A4 with eight protease inhibitors antiretroviral drugs. Alcohol Clin Exp Res. 2011;35:2121–2127.
- Midde NM, Gong Y, Cory TJ, et al. Influence of Ethanol on darunavir hepatic clearance and intracellular PK/PD in HIV-Infected monocytes, and CYP3A4-Darunavir interactions using inhibition and in silico binding studies. Pharm Res. 2017;34:1925–1933.
- Midde NM, Sinha N, Lukka PB, et al. Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells. PLoS ONE. 2017;12:e0172628.
- Rao PSS, Kumar S. Chronic effects of ethanol and/or Darunavir/Ritonavir on U937 monocytic cells: regulation of cytochrome P450 and antioxidant enzymes, oxidative stress, and cytotoxicity. Alcohol Clin Exp Res. 2016;40:73–82.
- Wang X, Douglas SD, Peng J-S, et al. Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes. J Leukoc Biol. 2006;79:1166–1172.
- Núñez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol. 2006;44:S132–S139.
- Kumar S, Sinha N, Gerth KA, et al. Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications. Biochem Biophys Res Commun. 2017;491:675–680.
- Rowland A, Ruanglertboon W, van Dyk M, et al. Plasma extracellular nanovesicle (exosome) derived biomarkers for drug metabolism pathways: a novel approach to characterise variability in drug exposure. Br J Clin Pharmacol. 2018;85:216–226.